Main article: Cancer (cancer)
Lung cancer mortality
Main article: Lung cancer mortality
Public persons who died of cancer
2025: Discontinuing publication of cancer mortality data
For the first time in several decades Herzen Moscow Cancer Research Institute , it did not include mortality statistics from cancer in the annual collection. It was based on forms Ministry of Health and statistics, Rosstat giving a detailed breakdown of mortality rates by region, sex, age and tumor species. However, since the summer of 2025, the statistics service has stopped publishing figures for major diseases, including cardiovascular and infectious diseases. This was State Dumas announced in November 2025 by a member of the Russian Health Protection Committee. In Alexey Kurinny[1]
2023
The increase in the number of deaths from cancer in the world by 74% compared to 1990 - up to 10.4 million people
In 2023, 18.5 million new cases of cancer and 10.4 million deaths due to malignancies were registered globally. This is 105% and 74% more, respectively, than in 1990. Such data at the end of September 2025 was published by the Lancet magazine.
The publication says that in the period from 1990 to 2023, there was a rapid increase in the number of newly diagnosed cancer diseases and deaths from it around the world, despite the successes achieved over the same period in the treatment of malignant formations and efforts to eliminate risk factors for their development. In 2023, breast cancer was the most commonly diagnosed cancer worldwide, while tracheal, bronchial and lung tumors became the leading cause of death among cancer patients.
The study notes that 42% (approximately 4.3 million) of the 10.4 million cancer deaths in 2023 were due to 44 potentially modifiable risk factors. Among them are tobacco smoking, unhealthy eating, excessive alcohol consumption, occupational risks, air pollution, obesity and high blood sugar. Moreover, tobacco is the leading risk factor in all countries, with the exception of low-income states, where unsafe sex is named as the leading reason, which accounts for 12.5% of all deaths from malignancies in such regions.
Experts believe that in the future the situation will continue to deteriorate. In particular, by 2050, the number of newly diagnosed cases of cancer is expected to increase globally to 30.5 million, which will correspond to an increase of 65% compared to 2023. The number of deaths from cancer will rise by 79% - to 18.6 million.[2]
In Russia, recorded the lowest mortality from cancer in 20 years
The one-year mortality rate of patients with oncology in Russia in 2023 was 18% against 21.7% in 2019. Ivan Stilidi, chief freelance oncologist of the Ministry of Health of the Russian Federation, director of the N.N. Blokhin National Medical Research Center, spoke about this at the end of February 2024.
 | A set of measures both for diseases of the circulatory system and in the oncological sphere also led to a decrease in mortality from malignant neoplasms. Over the past two years, this is the lowest figure in 20 previous years, mortality at the lowest level in 20 years, he said (quoted by Interfax). |  |
According to Stilidi, the five-year survival rate of patients who are being treated for cancer is also growing in Russia. The coverage of medical services of oncological patients was estimated by the chief freelance oncologist of the Ministry of Health of the Russian Federation at 76% at the end of 2023, which exceeds the 2021 figure (63.5%).
Ivan Stilidi believes that the federal project "Fight against Cancer" helped Russia "make a jump in development." In particular, the improvement in cancer control indicators was facilitated by the consolidation of the patient route, telemedicine consultations, improvement of the regulatory framework, and the provision of cancer care in specialized institutions.
In addition, at the expense of the federal budget, 11 oncological dispensaries were built and equipped with modern equipment, national medical centers were re-equipped, the system of outpatient oncological care centers was introduced (their number by February 2024 increased to 534).
According to Ivan Stilidi, thanks to the fact that cancer dispensaries are equipped with modern radiation facilities, it was possible to increase the number of patients who receive radiotherapy by 30%. The practice of oncologists includes radionuclide diagnosis and therapy of tumors, he added.[3]
Cancer mortality decreased in Russia in the first year after diagnosis
In Russia, the mortality rate of patients with cancer in the first year after diagnosis decreased from 23.6% in 2015 to 18.3% in 2023. In addition, there is an improvement in the detection rate of malignancies. This is stated in materials published in early April 2024.
As the chief freelance oncologist of the Ministry of Health of Russia, Director General of the Federal State Budgetary Institution "National Medical Research Center of Radiology," Academician of the Russian Academy of Sciences Andrei Kaprin told RIA Novosti, mortality from cancer in the first year after the detection of the disease in 2023 decreased by 4.7% compared to the previous year. At the same time, the detection rate of cancer improved by 8% compared to 2021.
In Russia,
According to estimates, in 2023 in Russia, malignant neoplasms were detected for the first time in life in 674,587 people. In 60% of these cases, cancer is found in the first or second stages. There is also a positive trend in the specific gravity of patients registered for five or more years. As Kaprin noted, in 2023 this figure was 58.8%.
| | We detect cancer more and more often, and therefore in the early stages, because this is a demographic indicator. We are now identifying somewhere around 425-427 people per 100 thousand population, "says Kaprin. | |
He also cited data from the World Health Organization (WHO), according to which 27 thousand people die from cancer in the world every day. Statistics suggest that approximately one in five people develops any cancer during their lifetime. About 1 in 9 men and 1 in 12 women die from cancer. The leading cause of death from cancer in 2022 was lung cancer, followed by colorectal cancer, liver cancer, breast cancer and stomach cancer.[4]
Ministry of Health - Cancer mortality in Russia has decreased by 6% in 6 years
In mid-September 2023, the Ministry of Health of the Russian Federation reported a decrease in cancer mortality in the country by almost 6% compared to 5 years ago.
| | We managed to reduce by 14% the one-year mortality rate of patients with malignant neoplasms, by 5.6% - the mortality rate of the population from malignant neoplasms compared to 2018, - the Minister of Health of the Russian Federation Murashko reported to the participants of the VI International Forum of Oncology and Radiotherapy "For Life." | |
This, according to the minister, also happened due to the fact that the use of anti-tumor drug therapy, including targeted drugs, has increased in Russia at the expense of compulsory medical insurance. According to him, the growth in five years was 63.6%.
Mikhail Murashko also stressed that the country is growing the share of oncological diseases detected in the early stages - it is already approaching 60%.
The mortality rate from neoplasms in Russia for four years decreased by 4.6%, the Deputy Prime Minister said on June 14, 2023 of the Russian Federation Tatyana Golikova during an inspection of the new complex of the Moscow Clinical Scientific Center named after A.S. Loginov.
She noted that over the past year, the number of examined cancer patients increased by 18.1%. In addition, she said that in Russia over four years, the indicator of cancer detection at the first and second stages has increased.
| | In Russia: [by] 5.1% better [detectability]<...> in Moscow, these indicators are multiple better, - added the Deputy Prime Minister. | |
In April 2023, Mikhail Murashko, at a meeting with Russian President Vladimir Putin, said that in Russia, mortality from cancer decreased by 4.5% in two years. Murashko also noted that in Russia, cancer patients have access to all types of treatment, including photon, proton and chemotherapy.[5]
2022
9.7 million people died from cancer in the world in a year
In August 2024, it became known that 9.7 million people died from cancer in the world in 2022. According to a study conducted by the International Agency for the Study of Cancer (IARC) and the American Cancer Society, about 20 million new cases of cancer were recorded during this period.
According to Kommersant, the largest number of deaths is caused by lung cancer - in 2022, this diagnosis led to the death of 1.8 million people. Lung cancer, as before, remains the most common and deadly type of cancer among both men and women. The disease accounts for 12.4% of all new cancer cases and 18.7% of total deaths. Other most common cancers are breast cancer (11.6%), colorectal cancer (9.6%), prostate cancer (7.3%), and stomach cancer (4.9%).
Scientists note that global statistics demonstrate an approximately equal ratio of sick men and women. However, men die from cancer significantly more often: among them, one in nine face this fatal diagnosis, while among women this figure is one in twelve. In addition, expert predictions indicate a significant increase in cancer morbidity and mortality in the future. By 2050, the number of new cases of cancer may increase by 77%, which will amount to more than 35 million cases annually. At the same time, the Earth's population is expected to increase to 9.7 billion people.
Scientists pay special attention to the increase in morbidity among men. By 2050, the number of cancer cases among men is projected to increase by 84%, and the number of deaths - almost doubled, reaching 10.5 million people. This trend is attributed to an aging population, as well as bad habits such as smoking and alcohol consumption, which significantly increase the risk of cancer.[6]
Survival rate of cancer patients in the United States has tripled in 50 years
According to the American Association for Cancer Research (AACR), the survival rate of cancer patients in the United States for 50 years has tripled: if in 1971 there were 3 million people recovered from cancer in the country, then by the beginning of 2022 - already 18 million people. The statistics were published in September 2022.
According to data to AARC, levels cancer deaths in the United States are steadily declining and more people than ever before are living longer and fuller lives after a cancer diagnosis. Since 2019, the number of cancer survivors in the United States has increased by more than 1 million. Declining rates smoking and significant improvements in early cancer detection are among the main reasons for these positive changes, according to the AACR.
The report provides the latest statistics on cancer incidence, mortality and survival, and discusses the latest research in the fields of etiology, biology, early detection, diagnosis, treatment and prevention of cancer, including the use of early detection systems based on AI and liquid biopsy, which are moving rapidly into the clinic.
The report also cited President Joe Biden's increased funding for cancer research under the administration's revived Cancer Moonshot initiative as key to even higher survival rates. In September 2022, Biden said that his goal is to reduce cancer deaths in the United States by at least half until 2037.
Although almost 3.5 million deaths from cancer were avoided between 1991 and 2019, more than 600 thousand people are expected to die from cancer in the United States in 2022, the report said. In the United States alone, the number of new cancers diagnosed each year will reach nearly 2.3 million by 2040, the AACR report predicts.
And many people, the report said, would die simply because they had no access to the latest treatments, trials or tests. Researchers note that there are two health systems in the US: one for people who can afford preventive services and quality treatment, and the other for everyone else[7]
2021
Reduction in 8.6% of 1-year mortality in patients with malignancies
For three years - from 2019 to 2021. - the mortality rate of Russians due to cancer decreased by 4.5%, and the one-year mortality rate in patients with malignant neoplasms fell by 8.6%, said the head of the Ministry of Health Mikhail Murashko at the end of July 2022 at a meeting of President Vladimir Putin with members of the government via videoconference.
According to the head of the Ministry of Health of the Russian Federation, over 3 years, the five-year survival rate in patients with cancer decreased by 5.5%.
In 2021, the Ministry of Health, together with the expert community "taking into account world experience," updated the "Procedure for medical examination and preventive medical examinations." It is argued that we are talking about malignant neoplasms of the most common localizations in Russia. Thanks to this, the share of malignant neoplasms detected at the first or second stages increased by 2.7%: from 56.4% in 2018 to 57.9% in 2021, the department said.
Unfortunately, despite all the efforts of the state, today the lack of concern among primary care doctors is insufficient for early and quick diagnosis of cancer, "Konstantin Tikhomirov, program director of the Tinkov Family Foundation, told Kommersant.
Hematologist, medical expert of the Foundation Andrei Abrosimov adds that, as a study on a similar topic shows more earlier, the optimal time for diagnosis is two to three weeks, with acute forms of the disease, for example, leukemia, "time is often counted for days and even hours." Yan Vlasov, co-chairman of the All-Russian Union of Patients, emphasizes that the issue of detection of oncology in the early stages in Russia has always been "very acute."
The Ministry of Health stressed that the increase in anti-anxiety among medical workers is a priority area of work within the framework of the approved regional programs "Fight against cancer."[8]
Mortality among cancer patients in Russia decreased by 5%
The mortality rate of patients with cancer in Russia in 2021 decreased by almost 5% compared to 2020. Such data on March 21, 2022 was cited by the Minister of Health of the Russian Federation Mikhail Murashko without specifying absolute indicators.
| | We managed to keep the mortality rates of the population in numbers below previous periods... It is the proactive detection of this category of diseases that is a priority for both the population and medical workers, "he said at a meeting with public receptions of United Russia. | |
According to Murashko, in the conditions of day and round-the-clock hospitals, the number of cancer patients in 2021 increased by 12%, the number of cases of treatment with the use of antitumor therapy increased by 12%. The availability of radiation therapy increased by almost 15% during 2021[9]
The general director of the Medskan group of companies (specializing in laboratory diagnostics), member of the board of the Association of Oncologists of Russia Andrei Modestov, in a conversation with Kommersant, draws attention to the continuing reduction in the number of patient visits.
According to him, the number of requests for primary diagnostics in 2021 decreased by 10-15% compared to 2020. At the same time, the expert is confident that "objectively" all the conditions for the systemic fight against cancer already exist.
| | But people are simply afraid to visit clinics even for an ordinary medical examination so as not to become infected with the COVID-19 coronavirus there. But if a person has a malignant neoplasm of non-external localization, then the disease is initially asymptomatic. And the fact that he was not diagnosed on time turns out only when he is brought to the hospital by an ambulance in serious condition, for example, with an obstruction of the intestines, he notes. | |
2020
Obesity-related cancer deaths triple in US in 20 years
Deaths from obesity-associated cancers in the U.S. tripled between 1999 and 2020. The age-adjusted figure rose from 2.73 cases to 13.52 cases per 1 million people. The largest increase was recorded among women and older people. The study was conducted by scientists from the University of Jersey Shore Medical Center. This became known in July 2025. Read more here.
Mortality from oncology in Russia decreased despite the COVID-19 pandemic
At the end of 2020, 556 thousand new cases of cancer were registered in Russia, including 256 thousand among men and 300 thousand among women. Russian Deputy Prime Minister Tatyana Golikova cited such data on October 27, 2021.
According to her, mortality from cancer in Russia in 2020 decreased by 1%, despite the COVID-19 coronavirus pandemic, due to which the volume of medical care not related to this infection was significantly reduced.
At the same time, a decrease in mortality from neoplasms in 2020 occurred in 81 regions of Russia, in Karachay-Cherkessia, the Jewish Autonomous Region, the Chukotka Autonomous Okrug, the Chelyabinsk Region and the Altai Republic, it was the most significant, Golikova noted.
The average Russian indicator of cancer incidence in 2020 amounted to almost 379 cases per 100 thousand population, in 29 subjects it turned out to be lower than the average. The minimal oncological incidence was demonstrated by the republics of Dagestan, Chechnya, Ingushetia, Tuva, Sakha - Yakutia, Altai, Kalmykia, as well as the Yamalo-Nenets, Chukotka and Khanty-Mansi Autonomous Okrugs.
The highest level in 2020 was detected in 10 regions: Sevastopol, Sakhalin, Samara, Oryol, Arkhangelsk, Yaroslavl, Kirov, Bryansk, Nizhny Novgorod, Kurgan regions, the Deputy Prime Minister said.
She also cited statistics on morbidity among children. In 2020, oncological diseases were detected in 3751 children, among them malignant neoplasms of lymphatic and hematopoietic tissue prevailed - acute leukemia, malignant neoplasms of the brain. Almost 29 thousand children from 0 to 17 years old were under observation.
In total, by the end of 2020, almost 4 million people, or 2.7% of the population, were under surveillance in Russia, 0.7% of them were children under 18 years old. Only 21% of those observed are rural residents.[10]
The number of deaths from respiratory cancer in the Russian Federation over 10 years decreased by 15%
The number of deaths from respiratory cancer in Russia over 10 years has decreased by 15%. This is stated in an article by the scientific journal Lancet Respiratory Medicine, published in August 2021.
The global mortality rate from lung cancer and other tumors in the respiratory system from 2010 to 2020. decreased by 5.7%. The incidence of all forms of malignant tumors affecting the lungs, trachea and other respiratory organs has decreased globally by 4.6%. The last indicator in developed countries decreased even more significantly, which was especially typical for men (-7.4%).
The study, which was conducted as part of the Global Burden of Disease (GBD) project, also states that the rate of death of patients from different forms of respiratory tract tumors among men has decreased by 8.7% over 10 years. In developed countries of the world, this figure decreased by 8.9%, while in low-income countries it increased by 3.7%.
Russia turned out to be one of the main leaders in this decline - the incidence of lung cancer and other neoplasms decreased by 13.9%. Among the male half of the population of the Russian Federation, the figure decreased by 19.7%.
In addition, the researchers analyzed whether the causes of malignant tumors in the respiratory organs had changed. These observations showed that smoking and air pollution continue to be the two main drivers in the development of lung cancer despite all efforts to combat both. According to the researchers, the increase in the incidence of respiratory cancer in developing countries is directly associated with both an increase in the number of smokers and a noticeable deterioration in air quality in these states. This must be taken into account when implementing policies aimed at combating both cancer and bad habits, the authors of the article summed up.[11]
The cancers that kill the most
In early April 2021, the American Society of Oncology published the results of the GLOBOCAN 2020 analysis prepared by the International Agency for the Study of Cancer. This article provided an update on morbidity and mortality from malignancies worldwide.
An estimated 19.3 million new cancers (18.1 million excluding non-melanoma skin cancer) and nearly 10.0 million cancer deaths (9.9 million excluding non-melanoma skin cancer) were reported worldwide in 2020.
Breast cancer bypassed lung cancer and became the most frequently detected malignancy in the world: 2.3 million new cases (11.7%). It is followed by lung cancer (11.4%), colorectal cancer (10.0%), prostate cancer (7.3%) and stomach cancer (5.6%).
Lung cancer remains the leading cause of cancer death, accounting for 1.8 million deaths (18%). It is followed by rectal cancer (9.4%), liver cancer (8.3%), stomach cancer (7.7%) and breast cancer (6.9%). Overall morbidity was 2-3 times higher in advanced economies compared to countries with economies in transition, whereas mortality varied among men and hardly differed among women. However, deaths from breast and cervical cancer in women were significantly higher in countries in transition compared to advanced economies (15.0/12.8 cases per 100,000 people and 12.4/5.2 cases per 100,000 people).
Cancer detection is expected to be 28.4 million cases in 2040, a 47% increase from 2020, with the largest increase in transition economies (64% to 95%) compared to advanced economies (32% to 56%) due to demographic changes[12]
Reduction in mortality from cancer in Russia by 1.5%
Mortality from cancer in Russia at the end of 2020 decreased by more than 1.5% compared to 2019. This indicator was named by the Minister of Health of the Russian Federation Mikhail Murashko on April 7, 2021 at the opening of the extraordinary XII Congress of Oncologists and Radiologists of the CIS Countries and Eurasia named after Trapeznikov N. N.
| | For such a severe pathology, these are good and important results, - said the head of the Ministry of Health of the Russian Federation. | |
According to him, it is important that, despite the pandemic, not a single bed intended for patients with cancer has been redesigned.
Earlier, Murashko said that timely assistance was provided to all cancer patients in full, despite the increased burden on the health care system amid the COVID-19 coronavirus pandemic.
At the same congress of oncologists and radiologists, the chief freelance oncologist Ministry of Health of the Russian Federation Andrey Kaprin cited updated data on mortality from neoplasms - in 2020, 289.9 thousand people died due to such diseases, which is 1.9% less than in 2019. He referred to the statistics of the Unified State Registry Office.
Most of all, the share of deaths from cancer at the end of 2020 decreased in Ivanovo (by 13.3%), Orlovskaya (by 12.4%) and Kostroma (by 9.1%) regions. In Moscow, the figure decreased by 3.5% - to 26.1 thousand deaths. The increase in mortality was shown by Tula (+ 9.8%), Bryansk (+ 4.8%) and Voronezh (+ 1.1%) regions.
The share of malignancies detected at an early stage in 2020 amounted to 56.1%, which is 2.3% lower than the previous year's indicator and 56.4% lower than the planned value of the federal project "Combating Cancer." The proportion of patients with cancer registered for 5 years or more increased by 2.2% and amounted to 56.5% (plan - 55.6%).[13]
2019
Child deaths from leukemia rise in Brazil - due to pesticides in soybean production
At the end of October 2023, American researchers reported that Brazil is experiencing an increase in infant mortality from leukemia. This is due to the fact that the country has significantly increased the production of soybeans associated with the use of pesticides and herbicides.
The work was attended by specialists from the University of Illinois at Urbana-Champaign, the University of Denver and the University of Wisconsin at Madison. The study covered the period from 2008 to 2019 in the biomes of serradu (an extensive ecoregion of tropical savanna in Brazil, Bolivia and Paraguay) and the Amazon. The researchers concluded that infant mortality from acute lymphoblastic leukemia correlates with pesticide exposure.
The report said that soybean production in the serradu region tripled from 2000 to 2019, while in the Amazon region the figure increased 20 times. This led to a sharp increase in the use of pesticides - 3-10 times. Experts report that an increase in soybean production by 10% leads to an increase in child mortality by 0.4 cases in the age group up to 5 years per 10,000 population. For children under the age of 10, the indicator increases by 0.21 deaths. In general, from 2008 to 2019, 226 deaths of children under 10 years old from acute lymphoblastic leukemia were registered in Brazil. At the same time, 123 children died precisely because of the impact of pesticides.
It is noted that the study affected primarily territories that are classified as "rural" and have at least 25% of land occupied in agriculture. Scientists believe that pesticide exposure to children occurs mainly through contamination of water sources.
| | Our concern is that our results are just the tip of the iceberg. Exposure to pesticides can also lead to non-fatal cases of leukemia, and there is a risk of influence on the adolescent and adult populations, the authors of the work emphasize.[14] | |
30% of US cancer deaths linked to smoking
30% of cancer deaths in the U.S. are related to smoking. This was reported in August 2022 by the American Cancer Society, the data were published in the International Journal of Cancer. Read more here.
294 thousand cancer patients died in Russia
Global cancer deaths rise 21% in 9 years
On December 30, 2021, researchers from the Institute for Health Metrics and Evaluation at the University of Washington in Seattle analyzed data on 29 cancer groups in 204 countries and concluded that cancer deaths in the world over 9 years increased by 21%. The paper was published in the monthly peer-reviewed medical journal JAMA Oncology.
In addition to increasing deaths and new cases, the latest estimates highlight global disparities in cancer burden, the authors said. The study describes cancer incidence, mortality, years of life with disability, years of life lost and disability-adjusted life years since 2010. Also included were global estimates for quintiles of socio-demographic index and comprehensive measure of education level, per capita income and total fertility rate for people under 25.
Globally, according to analysts, the total number of deaths from cancer in the world increased by 20.9% from 8.29 million in 2010 to 10 million in 2019. Similarly, the number of new cancer cases increased from 18.7 million in 2010 to 23.6 million in 2019, a 26.3% increase. According to estimates, in 2019 the number of deaths from cancer will be 250 million, which is 16% more than in 2010.
| | Efforts to prevent and control cancer need to be intensified to equitably address the developing and increasing burden of cancer across the spectrum of socio-demographic indicators. The increased burden of cancer in already overstretched and under-resourced countries is concerning given the existing disparities in access and health care coverage. Efforts to strengthen cancer control infrastructure, expand workforce capacity, increase access to universal health coverage and sufficient financial security will be critical, said research fellow at the Institute for Health Metrics and Evaluation and study author Jonathan Kocarnik. | |
The five leading cancer-related causes for both sexes combined in 2019, excluding other malignancies, were:
- Cancer of the trachea, bronchi and lungs;
- Colon and rectal cancer;
- Stomach cancer;
- Breast cancer;
- Liver cancer.
The researchers also found that the burden of cancer varies according to sociodemographic characteristics. The proportion of years lived with a disability that led increased with increasing wealth, ranging from 1.4% in the low-income quintile to 5.7% in the high-income quintile. While the high-income quintile recorded the highest number of new cases in 2019, and with the average, the highest number of cancer deaths were reported. Moreover, they predict that by 2040, more than two-thirds of the world's cancers will be in low- and middle-income countries.[15]
US cancer deaths fall 27% in 50 years
Significant progress has been made in reducing cancer deaths in the United States, according to a study published on November 11, 2021. Rates across all cancers, overall, declined 27% between 1971 and 2019.
According to a group led by Tyler Kratzer of the American Cancer Society, the mortality rate has dropped "significantly" for 12 of the 15 major cancer foci analyzed. The researchers also found a larger reduction in deaths from certain cancers in certain years, such as lung cancer, which was 44% lower in 2019 compared to its peak in 1993.
From 1999 to 2019, the mortality rate from cancer decreased by 27%, from 200.8 to 146.2 deaths per 100 thousand population. Cancer mortality decreased more among men (31%) than among women (25%), but still was higher among men (172.9 deaths per 100 thousand population) than among women (126.2 deaths per 100 thousand population).
Various factors contributed to this general trend. These include advances in surgery, radiotherapy, chemotherapy, precision medicine and combination therapy, and increased spending on the annual budget of the U.S. National Cancer Institute under the National Cancer Act of 1971. This increased the budget 25 times, from $227 million in 1971 to $6 billion in 2019, the team said.
However, there was also an increase in mortality in several categories, such as a 3% increase in pancreatic cancer and an 8% increase in esophageal and brain cancers. Cancer death rates were higher in the 29% of U.S. counties included in the analysis. They were mostly found in the south, the researchers added.
Kratzer et al. Called for improved equity through investment in social determinants of health and research to advance a national cancer control agenda.[16]
Mortality in cancer beds in Russia increased by 25%
Mortality in cancer beds in Russia in 2010-2019. increased by 25%. This is evidenced by the data of the Central Research Institute of Organization and Informatization of Health Care (TsNIIOIZ) of the Ministry of Health of the Russian Federation.
According to the study, the number of cancer beds around the clock in Russia over 10 years increased by 16.8%, to 36,186, due to an increase in the incidence of neoplasms in the population (by 24.9%), including malignant ones (1.5 times).
According to TsNIIIZ, the provision of specialized beds from 2010 to 2019 increased by 13.8% (from 2.17 to 2.47 per 10 thousand people), the level of hospitalization on them - by 57.4% (from 6.1 to 9.6 per thousand people). Mortality in cancer beds increased by a quarter - from 0.76% in 2010 to 0.95% in 2019, however, the average length of stay in a cancer bed decreased (from 12.1 to 8.4 days - by 30.6%) and the average occupancy of a bed in the year (from 345 to 330 days - by 4.3%).
The extreme values of the level of hospitalization for oncological beds by region in 2019 differ by 12.8 times, the provision of beds - by 9.2 times, the average occupancy of a bed per year - by 1.5 times, the average duration of stay in a bed - by 2.4 times.
According to the authors of the study, the growth of the round-the-clock bed capacity of oncoprofile in the regions was uneven and it needs to be optimized, taking into account the needs of the subjects and the development of alternative medical services.
As part of the study, using data from federal statistical observation by descriptive statistics, the main indicators of the incidence of neoplasms in the population, as well as the work of beds around the clock in the Russian Federation, federal districts and constituent entities in the dynamics of 2010-2019, were analyzed[17]
Cancer has become a leading cause of death in rich countries
In early September 2019, researchers announced that cancer was the leading cause of death in rich countries, overtaking cardiovascular disease. If current trends do not change, cancer could become the leading cause of death worldwide in just a few decades.
Publishing the results of two large studies in the medical journal The Lancet, scientists announced a new global "epidemiological transition" between different types of chronic diseases. Although cardiovascular disease remains the leading cause of death worldwide among middle-aged adults - accounting for 40% of all deaths - the trend is no longer among high-income countries, where cancer kills twice as many people as heart disease.
Cancer is the second most common cause of death in the world, accounting for 26% of all deaths. But as rates of cardiovascular disease continue to fall, it is possible that cancer will become the leading cause of death worldwide in just a few decades.
About 70% of all cases of cardiovascular disease and deaths are due to modifiable risk factors such as hypertension, high cholesterol, poor diet, smoking and other lifestyle aspects. In high-income countries, treatment with cholesterol-lowering statins and antihypertensive drugs has significantly reduced the incidence of cardiovascular disease over the past few decades. The team of researchers believes that the higher mortality rate from cardiovascular disease in low-income countries is mainly due to the poor quality of health care in these regions.[18]
Cancer deaths in the United States are declining, but more and more poor people are dying
On January 8, 2018, the American Cancer Society released an annual report according to which 1.8 million new cases of cancer will be diagnosed in the United States in 2019, and 606,880 Americans are expected to die from this disease.
According to statistics, the death rate in the United States decreased annually from 1991 to 2016. In 1991, the number of deaths from oncology reached a record level - 215.1 cases per 100 thousand people. However, then this figure decreased annually by about 1.5%, and by 2016 there were only 156 deaths from cancer per 100 thousand people in the US population.
At the same time, in poorer districts there is a significant increase in deaths from cancer. The imbalance is especially noticeable when it comes to lung cancer and cervical cancer. Compared to the wealthiest counties in the United States, cancer deaths in the poorest areas are twice as high for cervical cancer and 40% higher for lung cancer in men. In addition, until the early 1970s, mortality in poor areas of the United States from colon cancer was 20% lower than in the wealthy, and in 2016 it was 30% higher.
At the beginning of 2019, the most common cancers diagnosed in men are prostate, lung and colorectal cancers. Together, they account for 42% of all cases in men, with prostate cancer alone accounting for almost 1 in 5 new cases. For women, the 3 most common cancers are breast, lung and colorectal. Together, they account for half of all cases, with breast cancer alone accounting for 30% of new cases. A quarter of all cancer deaths are linked to lung cancer.
The rates of new cancer cases and deaths are quite different among racial and ethnic groups. The highest rates are among African Americans, the lowest among Asian Americans.
Racial and ethnic differences in incidence reflect several factors associated with socioeconomic status. People living in the poorest counties in the United States are more likely to smoke and be obese. Poverty is also associated with lower rates of cancer screening, late diagnosis and inability to receive good treatment.
Cancer is also the second most common cause of death among children ages 1 to 14 in the U.S. after accidents. It is projected to be diagnosed in about 11,060 children in this age group in 2019.
Each year, American Cancer Society researchers include a special section on the issue of cancer research or care in the report. In 2019, the topic of older people aged 85 years and older was considered. This age group is the fastest growing in the United States. Its numbers are expected to nearly triple from 6.4 million in 2016 to 19 million by 2060.
Cancer risk increases with age, and a rapidly aging nation will increase demand for its treatment. Diagnosis and treatment in this case are often complicated by other diseases.
Diet, exercise, screening and access to effective treatments are still the main means of fighting cancer, said Dr. Len Lichtenfeld of the American Cancer Society.[19][20]
2018: Poor people in the US get sick and die from cancer more often
On October 5, 2018, an article by researchers from Yale University was published in the journal JAMA Network Open. They identified factors that contribute to high cancer deaths by comparing rates among different regions of the United States. Researchers believe that many socioeconomic and behavioral factors influence the spread and mortality from cancer - in particular, poor people are more likely to get cancer and die from it. The study authors hope the findings will help public health experts identify specific targets to reduce cancer deaths.
Although cancer deaths have declined in the United States in recent decades, the rates differ significantly between regions, and this difference is becoming larger. To identify the factors that might be driving these differences, a team of Yale researchers analyzed publicly available data on cancer patients in different regions, comparing them across a range of metrics. The statistics of deaths of malignant neoplasms recorded from October 1, 2016 to July 31, 2017 were used. First of all, the researchers compared mortality in low, middle and high income regions, and then tried to identify specific risk factors affecting these differences.
The research team confirmed that there is indeed a statistically significant difference in cancer deaths between different regions of the United States, with high-income regions reporting 186 deaths per 100,000 people and low-income regions seeing 204 deaths per 100,000 people. In middle-income regions, the death rate was 230 cases per 100,000 people.
Analysis aimed at identifying the relationship between independent variables showed that most of the differences are due to a number of key factors. According to vowel researcher Jeremy O'Connor, MD, PhD, the most important of these factors is poor diet due to low income, smoking, sedentary living and poor quality of care provided in the region.
In total, the researchers identified eight risk factors. Behavioural factors include obesity, smoking, and low physical activity, health organization factors - inaccessibility of care, poor quality of care, as well as lack of laws to ban smoking in public places, and social ones are the inaccessibility of health insurance and food instability, which means the inability to regularly buy food. As Dr. O'Connor explained, the uneven distribution of cancer deaths is explained not by individual factors, but by their combination - socioeconomic factors are superimposed on behavioral and mutually weigh each other.
As part of their methodology, the researchers also created a map to visualize the imbalance in cancer mortality by territory. They suggest that health professionals not spend their energy adjusting all eight risk factors at the same time, but focus only on the most significant for their region. This approach will allow officials to throw all funds to solve specific problems available in the territory entrusted to them.
The researchers also highlight the fact that while overall cancer mortality rates depend on the emergence of new treatments, differences between regions are driven by factors associated with the country's prevention and socioeconomic development.[21]
2017: U.S. Mortality Reduction
At the end of March 2017, the American Cancer Society (ACS) reported a decrease in cancer deaths in the United States. The statistics were published in the Journal of the National Cancer Institute.
According to the results of the study, from 2010 to 2014, the number of deaths of cancer patients in the United States decreased by 1.8% per year in men, 1.4% in women and 1.6% in children.
A decrease in mortality over a four-year period was recorded in the case of 11 of the 16 most common malignant tumors in men and 13 of 18 in women, including for cancers of the lungs, colon and rectum, breast and prostate. At the same time, mortality increased from liver cancer ( in men and women), pancreas ( in men), brain ( in men) and uterus.
Between 1999 and 2013, the number of new cancers among men decreased, but women have stable dynamics in this regard.
The authors of the report attributed the reduction in the percentage of deaths in cancer patients to a decrease in tobacco smoking, as well as the fact that tumors began to be detected and treated more often in the early stages. By 2017, the number of Americans smoking is about 40 million, smoking remains the main cause of death from cancer.
The report contains a section on the survival rate of people found to have malignancies. In the case of some cancers, patients began to be cured more often at both early and late stages of the disease. At the same time, indicators vary depending on race and ethnicity, the condition of the patient and other factors. Thus, the total mortality from all forms of cancer among blacks is 33% higher than among the white population, and among the Indians and the Native population of Alaska the figure exceeds 51%.
Compared to the cases diagnosed in 1975-1977, the five-year cancer survival rate for the period 2006-2012 significantly improved for all types of diseases except cervical and uterine cancers. The greatest increase in survival (25% or more) was observed in prostate and kidney cancers, as well as non-Hodgkin lymphoma, myeloma and leukemia.
| | Although mortality-demonstrating trends most often serve as a measure of progress in the fight against cancer, survival trends are also an important indicator for monitoring progress in the treatment of cancer, said study author Ahmeddin Jemal, who works at ACS. | |
More effort and resources are needed to identify common cancers such as colon, breast and prostate cancers, the doctors said. In addition, doctors need to make more efforts to understand the trend of increasing cancer incidence of the uterus, female breast and pancreas.
Lisa Richardson, director of the U.S. Centers for Disease Control and Prevention, believes that the most important strategies for preventing cancer remain the fight against smoking and overweight.
Cancer deaths in the U.S. continue to decline. However, progress in reducing mortality and increasing survival for some forms of cancer is limited, which suggests the need for increased work to find new prevention, early detection and treatment strategies , as well as the widespread and equitable application of preventive measures with proven effectiveness, the authors of the report summarized.
The American Cancer Society annually collects and analyzes data on cancer morbidity and mortality in the United States. The study, published in March 2017, analyzed national data for 10 years - from 2000 to 2014.[22]
Notes
- ↑ Russia, stopped publishing data on mortality from oncology
- ↑ Cancer deaths expected to rise to over 18 million in 2050, nearly 75% more than in 2024
- ↑ The lowest mortality rate from malignant neoplasms in 20 years was noted in the Russian Federation
- ↑ In Russia, the mortality rate of cancer patients decreased in the first year of the disease
- ↑ Murashko reported a decrease in mortality from cancer in the Russian Federation by almost 6% in six years
- ↑ Smoking their main cancer
- ↑ New-treatments, -diagnostics-are-a-big-factor The Number of Cancer Survivors in the U.S. is at a Record High: How We Got Here
- ↑ Murashko: in three years, the mortality rate of cancer patients decreased by 4.5%
- ↑ Murashko: mortality among cancer patients in Russia in 2021 decreased by almost 5%
- ↑ Mortality from cancer in Russia decreased by 3.9%
- ↑ The number of deaths from tumors in the respiratory system over 10 years decreased by 5.7%
- ↑ Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- ↑ Murashko: mortality from cancer in Russia decreased by 1.5% in 2020
- ↑ Soy expansion in Brazil linked to increase in childhood leukemia deaths
- ↑ Cancer deaths increasing worldwide
- ↑ Cancer mortality declined by 27% over past five decades
- ↑ The round-the-clock bed capacity of the oncological profile in Russia increased by almost 17% over 10 years
- ↑ Cancer overtakes heart disease as biggest rich-world killer
- ↑ [1] Cancer in America Is Way Down, For the Wealthy Anyway US Cancer Death Rate Drops 27% in 25 Years
- ↑ [2]
- ↑ Cancer death disparities linked to poverty, lifestyle
- ↑ ACS: U.S. cancer death rates continue to fall
| The site content is translated by machine translation software powered by PROMT. The machine-translated articles are not always perfect and may contain errors in vocabulary, syntax or grammar. Read original article If you find inaccuracies or errors in the results of machine translation, please write to editor@tadviser.ru. We will make every effort to correct them as soon as possible. |